Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of version 2.3 of its Trial Simulator software to help drug developers improve clinical trial design, resulting in...
Multi-site clinical study brings together the best in class tumor-targeting imaging agent for brain cancer and the highest sensitivity NIR microscope-based detection device in late stage development Blaze Bioscience Inc., the Tumor Paint Company®, a biotechnology...
Tiziana Life Sciences plc (“Tiziana” or the “Company”) (Nasdaq: TLSA / AIM: TILS), a UK biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, previously announced that it had submitted...
Cold Genesys, Inc. today announced that it has entered into a clinical collaboration with Merck (known as MSD outside the United States and Canada) to evaluate the combination of Cold Genesys’ lead oncolytic immunotherapy candidate CG0070 with Merck’s anti-PD-1...
Clinerion has added a live heatmap to its homepage indicating prevalence of searchable disease indications by ICD10 code according to the global patient network in its Patient Network Explorer. Real-time statistics including the number of countries, sites and patients...
Email
Text